Search hospitals > New York > New Hyde Park
Don Monti Comprehensive Cancer Center at North Shore University Hospital
Claim this profileNew Hyde Park, New York 11042
Global Leader in Leukemia
Global Leader in Lung Cancer
Conducts research for Cancer
Conducts research for Breast Cancer
Conducts research for Pancreatic Cancer
99 reported clinical trials
5 medical researchers
Summary
Don Monti Comprehensive Cancer Center at North Shore University Hospital is a medical facility located in New Hyde Park, New York. This center is recognized for care of Leukemia, Lung Cancer, Cancer, Breast Cancer, Pancreatic Cancer and other specialties. Don Monti Comprehensive Cancer Center at North Shore University Hospital is involved with conducting 99 clinical trials across 135 conditions. There are 5 research doctors associated with this hospital, such as Veena John, MD, Marina Frimer, MD, Joanna Rhodes, MD, and Kevin M. Sullivan.Area of expertise
1Leukemia
Global LeaderFLT3 positive
2Lung Cancer
Global LeaderStage IV
Stage III
MET positive
Top PIs
Veena John, MDNorthwell Health/Center for Advanced Medicine2 years of reported clinical research
Studies Ovarian Cancer
Studies Fallopian Tube Cancer
12 reported clinical trials
23 drugs studied
Marina Frimer, MDNorthwell Health5 years of reported clinical research
Studies Uterine Cancer
Studies Endometrial Adenocarcinoma
6 reported clinical trials
28 drugs studied
Joanna Rhodes, MDRutgers Cancer Institute of New Jersey4 years of reported clinical research
Studies Follicular Lymphoma
Studies Non-Hodgkin's Lymphoma
7 reported clinical trials
17 drugs studied
Kevin M. SullivanNorthwell Health Imbert Cancer Center4 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
5 reported clinical trials
13 drugs studied
Clinical Trials running at Don Monti Comprehensive Cancer Center at North Shore University Hospital
Cancer
Follicular Lymphoma
Non-Hodgkin's Lymphoma
Lung Cancer
Relapse
Multiple Myeloma
Mixed-Cell Lymphoma
Solid Tumors
Non-Small Cell Lung Cancer
Renal Cell Carcinoma
Telisotuzumab Vedotin vs. Docetaxel
for Non-Small Cell Lung Cancer
This trial is testing a new drug called telisotuzumab vedotin to see if it can treat a specific type of lung cancer better than an existing drug. The study focuses on adults whose lung cancer has not responded to previous treatments. The new drug targets and kills cancer cells by attaching to a specific protein on their surface.
Recruiting2 awards Phase 312 criteria
ABBV-101
for Blood Cancers
This trial tests ABBV-101, a new drug for treating certain blood cancers, in adults who haven't responded to other treatments. It aims to find the safest dose and check if the drug can reduce cancer activity.
Recruiting1 award Phase 115 criteria
Targeted Therapy
for Advanced Stage Cancer
The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug. NOTE: Due to character limits, the arms section does NOT include all TAPUR Study relevant biomarkers. For additional information, contact TAPUR@asco.org, or if a patient, your nearest participating TAPUR site (see participating centers). \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\* Results in publication or poster presentation format are posted as they become available for individual cohorts at www.tapur.org/news. The results may be accessed at any time. All results will be made available on clinicaltrials.gov at the end of the study. Indexing of available results on PubMed is in progress. \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*
Recruiting1 award Phase 29 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Don Monti Comprehensive Cancer Center at North Shore University Hospital?
Don Monti Comprehensive Cancer Center at North Shore University Hospital is a medical facility located in New Hyde Park, New York. This center is recognized for care of Leukemia, Lung Cancer, Cancer, Breast Cancer, Pancreatic Cancer and other specialties. Don Monti Comprehensive Cancer Center at North Shore University Hospital is involved with conducting 99 clinical trials across 135 conditions. There are 5 research doctors associated with this hospital, such as Veena John, MD, Marina Frimer, MD, Joanna Rhodes, MD, and Kevin M. Sullivan.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.